Cutaneous Adverse Events of Osimertinib in Diverse Patient Populations with EGFR-mutated Non-Small Cell Lung Cancer: A Retrospective Cohort Analysis

Name: Cutaneous Adverse Events of Osimertinib in Diverse Patient Populations with EGFR-mutated Non-Small Cell Lung Cancer: A Retrospective Cohort Analysis
Creator: Daniel Alicea
Published: 2024-11-07T13:57:42.059Z
Keywords: Dermatology, Oncology

Alicea, Daniel; Miao, PharmD, MD, Emily; Ch'en, Peter; Tuckman, MBA, Steven W.; Ohri, MD, MS, Nitin; Halmos, MD, Balazs; Cheng, MD, PhD, Haiying; Lee, MD, MPH, Matthew; McLellan, MD, Beth N.

doi:10.17632/87nhm59g4t.1

Cutaneous Adverse Events of Osimertinib in Diverse Patient Populations with EGFR-mutated Non-Small Cell Lung Cancer: A Retrospective Cohort Analysis

Published: 7 November 2024| Version 1 | DOI: 10.17632/87nhm59g4t.1

Contributors:

Daniel Alicea, Emily Miao, PharmD, MD, Peter Ch'en, Steven W. Tuckman, MBA, Nitin Ohri, MD, MS, Balazs Halmos, MD, Haiying Cheng, MD, PhD, Matthew Lee, MD, MPH, Beth N. McLellan, MD

Description

A Kaplan Meier curve seen in supplemental Figure 1 was conducted to assess overall survival (OS) among racial/ethnic groups; results showed that Non Hispanic Whites and Asians have a longer OS compared to Non Hispanic Blacks and Hispanics/Latinos (p=0.026).

Files

Steps to reproduce

Kaplan-Meier curves were generated for overall survival and log-rank test compared the curves between patients.

Cutaneous Adverse Events of Osimertinib in Diverse Patient Populations with EGFR-mutated Non-Small Cell Lung Cancer: A Retrospective Cohort Analysis

Description

Files

Steps to reproduce

Categories

Licence